Kneipp Group has acquired Pierre Cattier
Kneipp France, a wholly owned subsidiary of the Kneipp Group in Würzburg, Germany, has acquired the French natural cosmetics manufacturer Pierre Cattier. Financial terms of this transaction have not been disclosed.
The Kneipp brand is synonymous with effective, innovative and natural product concepts for health and well-being based on the holistic teachings of Sebastian Kneipp. The Kneipp Group operates worldwide and is a wholly owned subsidiary of Paul Hartmann AG, Heidenheim. The company is looking to further strengthen its position in Germany and internationally by means of acquisitions.
Dietmar Salein, Managing Director of the Kneipp Group, and Daniel Aressy, the owner of Pierre Cattier, signed the purchase agreement for the acquisition of all shares of Pierre Cattier. Kneipp France and Pierre Cattier have merged into one company and will continue to operate under the name Pierre Cattier in France. The new company will be led by Cattier’s Managing Director Alexis Fort and will market both product lines.
Pierre Cattier has been producing and marketing certified natural cosmetics since 1968. Cattier products are organic cosmetics with no parabens, synthetic dyes or fragrances, and no paraffin oil.
Oaklins' team in Germany advised the Kneipp Group on the acquisition process by initiating the transaction and running a structured international search in Germany, Austria, Switzerland and France with the support of Oaklins' teams in Switzerland and France. After having identified a French transaction target, our German and France teams jointly concluded the process from originating the contact with the seller, reviewing the documentation, coordinating the due diligence and advising on the negotiations through to the successful closing of the transaction.
Talk to the deal team
Related deals
AWC has acquired a significant minority stake in MyFitness
AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.
Learn moreKaviari has received a minority investment from idiCo
Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn more